We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Keytruda is an anti-programmed death receptor-1 (PD-1) therapy that increases the ability of the patient’s immune system to help detect and combat tumour cells.